Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The closing price of Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) was $3.23 for the day, up 3.19% from the previous closing price of $3.13. In other words, the price has increased by $3.19 from its previous closing price. On the day, 3.63 million shares were traded. IRWD stock price reached its highest trading level at $3.34 during the session, while it also had its lowest trading level at $3.08.
Ratios:
Our analysis of IRWD’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.74 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 7.77. For the most recent quarter (mrq), Quick Ratio is recorded 1.13 and its Current Ratio is at 1.13.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 17 ’25 when Gaskins Tammi L sold 6,016 shares for $3.32 per share. The transaction valued at 19,973 led to the insider holds 235,264 shares of the business.
Gaskins Tammi L bought 6,324 shares of IRWD for $21,312 on Nov 17 ’25. On Aug 11 ’25, another insider, Gaskins Tammi L, who serves as the Chief Commercial Officer of the company, sold 1,316 shares for $0.84 each. As a result, the insider received 1,105 and left with 241,280 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IRWD now has a Market Capitalization of 525452000 and an Enterprise Value of 983285056. As of this moment, Ironwood’s Price-to-Earnings (P/E) ratio for their current fiscal year is 20.92, and their Forward P/E ratio for the next fiscal year is 7.23. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.55. Its current Enterprise Value per Revenue stands at 2.901 whereas that against EBITDA is 6.75.
Stock Price History:
The Beta on a monthly basis for IRWD is 0.20, which has changed by -0.32104123 over the last 52 weeks, in comparison to a change of 0.13153219 over the same period for the S&P500. Over the past 52 weeks, IRWD has reached a high of $5.13, while it has fallen to a 52-week low of $0.53. The 50-Day Moving Average of the stock is 20.47%, while the 200-Day Moving Average is calculated to be 126.52%.
Shares Statistics:
IRWD traded an average of 2.31M shares per day over the past three months and 2928480 shares per day over the past ten days. A total of 162.68M shares are outstanding, with a floating share count of 156.69M. Insiders hold about 3.68% of the company’s shares, while institutions hold 91.66% stake in the company. Shares short for IRWD as of 1764288000 were 7464531 with a Short Ratio of 3.23, compared to 1761868800 on 4762545. Therefore, it implies a Short% of Shares Outstanding of 7464531 and a Short% of Float of 6.950000000000001.
Earnings Estimates
The dynamic stock of Ironwood Pharmaceuticals Inc (IRWD) is currently attracting attention from 2.0 analysts actively involved in rating its market status.The consensus estimate for the next quarter is $0.02, with high estimates of $0.08 and low estimates of -$0.04.
Analysts are recommending an EPS of between $0.32 and $0.27 for the fiscal current year, implying an average EPS of $0.29. EPS for the following year is $0.46, with 3.0 analysts recommending between $0.5 and $0.41.
Revenue Estimates
It is expected that $90B in revenue will be generated in. The current quarter, according to 3 analysts. It ranges from a high estimate of $60.6M to a low estimate of $57M. As of. The current estimate, Ironwood Pharmaceuticals Inc’s year-ago sales were $90.55MFor the next quarter, 3 analysts are estimating revenue of $38.2M. There is a high estimate of $38.2M for the next quarter, whereas the lowest estimate is $38.2M.
A total of 3 analysts have provided revenue estimates for IRWD’s current fiscal year. The highest revenue estimate was $309.1M, while the lowest revenue estimate was $305.6M, resulting in an average revenue estimate of $306.97M. In the same quarter a year ago, actual revenue was $351.41MBased on 3 analysts’ estimates, the company’s revenue will be $319.47M in the next fiscal year. The high estimate is $334.2M and the low estimate is $310.2M.
